Theriva Biologics, Inc. Gain (Loss) on Disposition of Property (Deprecated 2013-01-31)
Theriva Biologics, Inc. (TOVX) reported Gain (Loss) on Disposition of Property (Deprecated 2013-01-31) of $0 for the 12-month period ending 2012-12-31, per its 10-K filed 2013-04-16.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfProperty · last filed 2013-04-16
- Theriva Biologics, Inc. gain (loss) on disposition of property (deprecated 2013-01-31) for the quarter ending 2012-12-31 was $0.00.
- Theriva Biologics, Inc. gain (loss) on disposition of property (deprecated 2013-01-31) for the quarter ending 2011-12-31 was $0.00.
- Theriva Biologics, Inc. gain (loss) on disposition of property (deprecated 2013-01-31) for fiscal 2012 was $0.00.
- Theriva Biologics, Inc. gain (loss) on disposition of property (deprecated 2013-01-31) for fiscal 2011 was -$6.00K.
| Period end | Gain (Loss) on Disposition of Property (Deprecated 2013-01-31) 3 month | Gain (Loss) on Disposition of Property (Deprecated 2013-01-31) 9 month | Gain (Loss) on Disposition of Property (Deprecated 2013-01-31) 12 month |
|---|---|---|---|
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-16 | $0.00 10-K · filed 2013-04-16 | |
| 2012-09-30 | $0.00 10-Q · filed 2012-11-14 | ||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-16 | -$6.00K 10-K · filed 2013-04-16 | |
| 2011-09-30 | -$6.00K 10-Q · filed 2012-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |